secwatch / observer
8-K filed January 24, 2023, 6:59 PM ET ticker EHTH CIK 0001333493
earnings confidence high sentiment positive materiality 0.75

eHealth Q4 prelim rev $190-200M, FY rev $395-405M; narrower adjusted EBITDA loss vs guidance

eHealth, Inc.

2022-FY EPS reported -$4.36 revenue$405,356,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

eHealth, Inc. reported the fourth quarter and fiscal year ended December 31, 2022 results: revenue Revenue for the fourth quarter of 2022 is expected to be in the range of $190 to $200 million. Revenue for the year ende, net income GAAP net income for the fourth quarter of 2022 is expected to be in the range of $16 to $21 million. GAAP net loss for t.

Period
the fourth quarter and fiscal year ended December 31, 2022
Revenue
Revenue for the fourth quarter of 2022 is expected to be in the range of $190 to $200 million. Revenue for the year ende
Net income
GAAP net income for the fourth quarter of 2022 is expected to be in the range of $16 to $21 million. GAAP net loss for t
Result
preliminary results
Exact text from the filing
• Revenue for the fourth quarter of 2022 is expected to be in the range of $190 to $200 million. Revenue for the year ended December 31, 2022 is expected to be in the range of $395 to $405 million as compared to the company’s guidance of $375 to $395 million. • GAAP net income for the fourth quarter of 2022 is expected to be in the range of $16 to $21 million. GAAP net loss for the year ended December 31, 2022 is expected to be in the range of $93 to $88 million as compared to the company’s guidance of $115 to $92 million.
View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

eHealth, Inc. filing history →

Source: SEC EDGAR
accession 0001333493-23-000006
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.